Dr. Shirin Kalyan is an Adjunct Professor with the Department of Medicine at University of British Columbia, the Scientist leading the Answer Factory at BC Children’s Hospital Research Institute, and the Director of Scientific Innovation at Qu Biologics, a clinical-stage Vancouver based biotech with an innovative immunotherapy platform that uses bugs as drugs to treat immune-related diseases. She earned her PhD from the University of British Columbia in Experimental Medicine investigating the pivotal innate immune mediators of inflammation in the context of toxic shock syndrome. As a Humboldt Fellow, Dr. Kalyan spent three years at the Institute of Immunology in Kiel understanding how bisphosphonates, the standard of care for bone loss and osteolytic bone disease, affect immune function and antioxidant capacity. Her research interests include determining how to optimally support immune function in the context of cancer and chronic inflammatory diseases and understanding how drug therapies commonly used to treat chronic degenerative disorders affect immune integrity.
Immunotherapy, Innate Immunity, Chronic Inflammatory Disorders, Cancer, Metabolic Bone Diseases, Translational Research, Biotechnology
Cancer Immunotherapy, Immune-endocrine, Cross-regulation, Osteoporosis, Ovulatory, Disturbance Reproductive Endocrinology
Reproductive Infectious Diseases Woman's Cancer Chronic Disease